sb 203580 has been researched along with 1,2,4-triazole in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (1,2,4-triazole) | Trials (1,2,4-triazole) | Recent Studies (post-2010) (1,2,4-triazole) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 496 | 1 | 370 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alam, O; Amir, M; Tariq, S | 1 |
1 other study(ies) available for sb 203580 and 1,2,4-triazole
Article | Year |
---|---|
Synthesis, p38α MAP kinase inhibition, anti-inflammatory activity, and molecular docking studies of 1,2,4-triazole-based benzothiazole-2-amines.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzothiazoles; Dose-Response Relationship, Drug; Female; Imidazoles; Male; Molecular Docking Simulation; Molecular Structure; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Wistar; Structure-Activity Relationship; Triazoles | 2018 |